US 8614301
Methods of treating cancer using anti CD24 antibodies
granted A61KA61K2039/505A61K39/39558
Quick answer
US patent 8614301 (Methods of treating cancer using anti CD24 antibodies) held by The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center
- Grant date
- Tue Dec 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K39/39558, A61P, A61P35/00